{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "0a40c228",
   "metadata": {},
   "source": [
    "# Exploratory Data Analysis: Cochrane Reviews & References\n",
    "\n",
    "**Objective:** Understand the structure and quality of the downloaded data before building the LLM screening pipeline.\n",
    "\n",
    "Key questions:\n",
    "1. How many Cochrane reviews do we have? What's the year distribution?\n",
    "2. Are there missing abstracts or titles?\n",
    "3. How many references per review? How many have resolvable PMIDs?\n",
    "4. Can we identify \"included\" vs \"excluded\" papers from the reference graph?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "8574c744",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data directory: c:\\Users\\juanx\\Documents\\LSE-UKHSA Project\\Data\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from pathlib import Path\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Paths\n",
    "DATA_DIR = Path.cwd().parent / \"Data\" if not (Path.cwd() / \"Data\").exists() else Path.cwd() / \"Data\"\n",
    "ABSTRACTS_CSV = DATA_DIR / \"cochrane_pubmed_abstracts.csv\"\n",
    "REFERENCES_CSV = DATA_DIR / \"cochrane_pubmed_references.csv\"\n",
    "\n",
    "print(f\"Data directory: {DATA_DIR}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6511984b",
   "metadata": {},
   "source": [
    "## 1. Load and Inspect Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "a777df8c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total Cochrane reviews: 17,092\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "pmid",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "title",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "abstract",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "journal",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "year",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "authors",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "b89d5f73-72e5-41ae-9a15-92efe64a7062",
       "rows": [
        [
         "0",
         "41527994",
         "Surgical interventions for treating vesicovaginal fistula in women.",
         "This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of surgical interventions for treating vesicovaginal fistula in women.",
         "The Cochrane database of systematic reviews",
         "2026",
         "Okada Y; Matsushita T; Hasegawa T; Noma H; Ota E; Achila B; Yoshimura Y"
        ],
        [
         "1",
         "41524153",
         "Physiology- versus angiography-guided percutaneous coronary intervention for people with coronary artery disease.",
         "This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objectives To evaluate the benefits and harms of physiology-guided PCI compared to angiography-guided PCI for cardiovascular events in individuals with CCS and ACS. Secondary objectives To assess potential differences in the effectiveness and safety of physiology-guided PCI according to patient characteristics, including sex and age, from the perspective of equity.",
         "The Cochrane database of systematic reviews",
         "2026",
         "Higuchi S; Yamaji N; Noma H; Ito M; Yokota Y; Ota E; Hasegawa T"
        ],
        [
         "2",
         "41510790",
         "Cladribine for people with multiple sclerosis.",
         "RATIONALE: Multiple sclerosis (MS) is a chronic, degenerative, autoimmune-mediated disease of the central nervous system (CNS). Although its pathogenesis is not fully understood, inflammation involving both T and B cells is considered an essential factor. Cladribine induces targeted lymphocyte depletion in the peripheral and central nervous system, potentially lowering inflammation and slowing disease progression. OBJECTIVES: To assess the short- and long-term benefits and harms of cladribine compared to no intervention, placebo, or any other disease-modifying drugs (DMDs) in people with any form of multiple sclerosis (MS). SEARCH METHODS: We searched the Cochrane MS and Rare Diseases of the CNS Trials Register (part of CENTRAL), MEDLINE, Embase, CINAHL, LILACS, major trials registries, and conference abstracts up to 3 February 2025. ELIGIBILITY CRITERIA: We included randomised controlled trials (RCTs), their open-label extension trials (OLEs), the first phase of cross-over trials, and non-randomised studies of interventions (NRSIs) that investigated cladribine, alone or in combination, at any dose or duration versus no intervention, placebo, or any other DMDs. Participants had a confirmed diagnosis of MS or clinically isolated syndrome according to accepted criteria. We excluded retrospective studies and studies without a comparison group. OUTCOMES: Critical outcomes Number of participants at the end of follow-up: with at least one serious adverse event (SAE), free from disability worsening, with no evidence of disease activity (NEDA), who withdrew from treatment, and with cognitive impairment; and quality of life. Important outcomes Number of participants at the end of follow-up with: at least one advert event, at least one new relapse, and new gadolinium-enhancing positive T1-weighted (Gd+ T1) or new/enlarging T2-weighted magnetic resonance imaging (MRI) lesions. RISK OF BIAS: We used the Cochrane risk of bias tools RoB 2 (for RCTs and OLEs) and ROBINS-I (for NRSIs). SYNTHESIS METHODS: We conducted random-effects meta-analyses to calculate risk ratios (RRs) with 95% confidence intervals (CIs), assessing RCTs, OLEs, and NRSIs separately. We assessed the certainty of evidence using GRADE. INCLUDED STUDIES: We included 15 studies: nine RCTs (follow-up 52-96 weeks; 2571 participants), two medium-term follow-up OLEs (24-96 weeks; 915 participants), two long-term follow-up OLEs (9.5-11.4 years), one NRSI with one year of follow-up (37 participants in cladribine group vs 599 in interferon beta [IFN-beta], fingolimod, and natalizumab groups), and one NRSI with three years of follow-up (633 participants in cladribine group vs 2842 in fingolimod, dimethyl fumarate, and teriflunomide groups). Three reports assessed MRI outcomes. No studies reported quality of life or cognitive impairment. SYNTHESIS OF RESULTS: Randomised controlled trials Cladribine compared to placebo may have little to no effect on the risk of SAEs (RR 1.08, 95% CI 0.80 to 1.45; 8 studies, 2495 participants) and treatment withdrawal (RR 1.43, 95% CI 0.77 to 2.66; I(2) = 76%; 8 studies, 2503 participants), but the evidence for both outcomes is very uncertain. Cladribine may have little to no effect on the number of people remaining free from disability worsening up to 24 months (RR 1.05, 95% CI 0.96 to 1.16; 3 studies, 1549 participants; low certainty). Cladribine compared to placebo may increase the risk of any adverse events, but the evidence is very uncertain (RR 1.14, 95% CI 1.02 to 1.28; 8 studies, 2405 participants). Cladribine likely reduces the risk of new relapses (RR 0.53, 95% CI 0.45 to 0.62; 2 studies, 1498 participants; moderate certainty), and it may reduce the risk of new Gd+ T1 MRI lesions, although the results are heterogeneous and the evidence is very uncertain (RR 0.30, 95% CI 0.19 to 0.47; I(2) = 79%; 4 studies, 2153 participants). Open-label extension trials With follow-up beyond two years, cladribine compared to placebo may have little to no effect on the risk of SAEs (RR 0.89, 95% CI 0.60 to 1.33; 2 studies, 915 participants), freedom from disability worsening (RR 1.02, 95% CI 0.93 to 1.11; 1 study, 806 participants), and treatment withdrawal (RR 0.93, 95% CI 0.81 to 1.08; 2 studies, 915 participants), but the evidence is very uncertain for all three outcomes. Cladribine may increase the proportion of people with NEDA at four years (RR 1.63, 95% CI 1.23 to 2.16; 2 studies, 662 participants; low certainty). Cladribine compared to placebo may have little to no effect on the risk of any adverse events (RR 1.04, 95% CI 0.96 to 1.12; 2 studies, 916 participants) and may reduce relapses at long-term follow-up (RR 0.68, 95% CI 0.59 to 0.79; 2 studies, 662 participants), but the evidence is very uncertain for both outcomes. In one study, cladribine reduced new Gd+ T1 MRI lesions, but the evidence is very uncertain (RR 0.68, 95% CI 0.52 to 0.88; 806 participants). Non-randomised studies of interventions Observational comparisons (1 study) showed reductions in relapse over three years with cladribine versus: * dimethyl fumarate (RR 0.57, 95% CI 0.38 to 0.88; low certainty); * teriflunomide (RR 0.30, 95% CI 0.20 to 0.47; moderate certainty); and * fingolimod (RR 0.51, 95% CI 0.36 to 0.74; moderate certainty). However, the evidence is very uncertain for the effect of cladribine on relapse over 12 months versus: * fingolimod (RR 1.05, 95% CI 0.52 to 2.10; very low certainty); * natalizumab (RR 1.25, 95% CI 0.58 to 2.71; very low certainty); and * interferon beta (RR 0.65, 95% CI 0.26 to 1.62; very low certainty). AUTHORS' CONCLUSIONS: Cladribine is an oral treatment for adults with MS requiring few monitoring visits and only short courses over two years, thereby reducing treatment burden, with a safety profile that appears acceptable based on very low-certainty evidence. Evidence from RCTs suggests cladribine likely reduces new relapses, may reduce new Gd+ T1 MRI lesions (although the evidence is very uncertain), but may have little to no effect on slowing disability progression. Results from OLEs showed cladribine may increase the proportion of people with NEDA at four years. Benefits in subgroups and for some critical outcomes remain uncertain due to the paucity of studies. Further high-quality controlled trials and patient-centred pragmatic registries are needed to strengthen the evidence base. FUNDING: This Cochrane review had no dedicated funding. REGISTRATION: Protocol available via https://doi.org/10.1002/14651858.CD013524.",
         "The Cochrane database of systematic reviews",
         "2026",
         "Celani MG; Orso M; Melis M; Ercolani MV; Cantisani TA"
        ],
        [
         "3",
         "41510785",
         "Oral iron supplements for children in malaria-endemic areas.",
         "RATIONALE: Iron deficiency anaemia is a common nutritional disorder among children in malaria-endemic regions and is associated with adverse developmental and health outcomes. However, concerns have been raised that iron supplementation might increase the risk of malaria by enhancing parasite growth, particularly in areas lacking adequate malaria prevention and treatment services. OBJECTIVES: To evaluate the effects and safety of iron supplementation, with or without folic acid, in children living in areas with hyperendemic or holoendemic malaria transmission, where malaria is intense and occurs year-round. SEARCH METHODS: We searched CENTRAL (Wiley), MEDLINE (Ovid), Embase (Ovid), and Global Index Medicus (WHO) up to 30 April 2024. We also searched two trial registries, ClinicalTrials.gov and WHO ICTRP, to 30 April 2024. We conducted a top-up search on 20 May 2025. We contacted trial investigators and scanned references of included trials and reviews for relevant studies. ELIGIBILITY CRITERIA: We included individual and cluster-randomised controlled trials (RCTs) conducted in malaria-endemic regions that enrolled children under 18 years of age. We included trials that compared: (1) oral iron alone versus placebo or no treatment; (2) oral iron plus folic acid versus placebo or no treatment; (3) oral iron (with or without folic acid) versus placebo or no treatment, grouped by malaria prevention and management services for the outcome of clinical malaria only; and (4) oral iron plus antimalarial treatment versus placebo or no treatment. Iron or fortified interventions had to provide >/= 80% of age-appropriate Recommended Dietary Allowance (RDA). Antihelminthics and micronutrients other than iron and folic acid had to be administered equally to both groups. OUTCOMES: The critical outcomes were clinical malaria, severe malaria, and death from any cause. Important outcomes included hospitalisations and clinic visits. RISK OF BIAS: We assessed risk of bias in the included trials using the Cochrane RoB 1 tool. SYNTHESIS METHODS: We used fixed-effect meta-analysis (Mantel-Haenszel or generic inverse variance) and adjusted for clustering in cluster-RCTs. For haemoglobin and anaemia outcomes, we applied a random-effects model due to anticipated heterogeneity. We assessed the certainty of evidence using GRADE and explored heterogeneity through subgroup analysis. INCLUDED STUDIES: Forty trials (33,785 children) met the inclusion criteria. SYNTHESIS OF RESULTS: Iron versus placebo/no treatment Iron results in little or no difference in the risk of clinical malaria (risk ratio (RR) 0.93, 95% confidence interval (CI) 0.87 to 1.00; 16 trials, 7843 children; high-certainty evidence) and reduces the risk of severe malaria slightly (RR 0.90, 95% CI 0.81 to 0.98; 5 trials, 3421 children; high-certainty evidence). Iron may result in little or no difference in mortality (RR 1.15, 95% CI 0.76 to 1.74; 20 trials, 8809 children; low-certainty evidence) and hospitalisations or clinic visits (RR 0.99, 95% CI 0.95 to 1.04; 10 trials, 14,011 children; low-certainty evidence). Iron plus folic acid versus placebo/no treatment The evidence for this comparison comes largely from one large trial (Pemba) plus four smaller trials (19,456 children). Clinical malaria was not reported. Iron plus folic acid may result in little to no difference in severe malaria requiring admission (RR 1.11, 95% CI 0.96 to 1.28; 2 trials, 17,575 children; low-certainty evidence); all-cause mortality (RR 1.13, 95% CI 0.90 to 1.42; 5 trials, 18,034 children; low-certainty evidence); and hospitalisations (RR 1.08, 95% CI 0.96 to 1.22; 1 trial, 15,956 children; low-certainty evidence). Iron (with or without folic acid) versus placebo/no treatment; grouped by presence or absence of malaria prevention and management services We also grouped trials by the presence of malaria prevention and management services, analysing 19 trials (25,531 children). In areas with services, iron (with or without folic acid) may reduce clinical malaria slightly (RR 0.91, 95% CI 0.84 to 0.97; 12 trials, 5777 children; low-certainty evidence). In areas without services, iron (with or without folic acid) may increase clinical malaria slightly (RR 1.15, 95% CI 1.02 to 1.30; 7 trials, 19,754 children; low-certainty evidence). Overall, when not grouping by presence of malaria prevention and management services, iron supplementation (with or without folic acid) may have little to no effect on clinical malaria (RR 0.96, 95% CI 0.91 to 1.03; 19 trials, 25,531 children; low-certainty evidence). Iron plus antimalarial prophylaxis versus placebo/no treatment Adding iron to antimalarial prophylaxis results in a large reduction in clinical malaria (RR 0.54, 95% CI 0.43 to 0.67; 3 trials, 728 children; high-certainty evidence); likely results in a large reduction in hospitalisations and clinic visits (RR 0.85, 95% CI 0.81 to 0.89; 2 trials, 5976 child-months; moderate-certainty evidence); and may not reduce all-cause mortality (RR 1.05, 95% CI 0.52 to 2.11; 3 trials, 728 children; low-certainty evidence). Severe malaria was not reported for this comparison. AUTHORS' CONCLUSIONS: Iron treatment results in little to no difference in the risk of clinical malaria (high-certainty evidence). Where resources are limited, iron can be administered without screening for anaemia or iron deficiency, as long as malaria prevention or management services are provided efficiently. Where resources for the prevention and treatment of malaria are limited, iron may increase the risk of clinical malaria (low-certainty evidence). These conclusions are consistent with those reported in the previous version of this review (2016). FUNDING: The editorial base for the Cochrane Infectious Diseases Group (CIDG) is funded by the UK Department for International Development for the benefit of developing countries. Dafna Yahav (DY) received a grant from the Research Programme Consortium funded by the UK Department for International Development to complete the 2014 update. Ami Neuberger (AN) received funding from the Department of Nutrition for Health and Development, World Health Organization, for the 2016 update. REGISTRATION: Protocol (2007) DOI: 10.1002/14651858.CD006589 Original review (2009) DOI: 10.1002/14651858.CD006589.pub2 Review update (2011) DOI: https://doi.org/10.1002/14651858.CD006589.pub3 Review update (2016) DOI: 10.1002/14651858.CD006589.pub4.",
         "The Cochrane database of systematic reviews",
         "2026",
         "Itzkovich M; Neuberger A; Harris I; Yahav D; Paul M; Gilboa M"
        ],
        [
         "4",
         "41500513",
         "Exercise for depression.",
         "RATIONALE: Depression is a common cause of morbidity and mortality worldwide. Depression is often treated with antidepressants or psychological therapy, or both, but some people may prefer alternative approaches such as exercise. This review updates one first published in 2008 and last updated in 2013. OBJECTIVES: To determine the effectiveness of exercise in the treatment of depression in adults compared with no intervention, waiting list control or placebo, or where exercise is used as an adjunct to an established treatment that is received by both exercising and non-exercising groups. To determine the effectiveness of exercise compared with other active interventions for depression in adults (psychological therapies, pharmacological treatments or alternative interventions such as light therapy). SEARCH METHODS: We searched the Cochrane Depression, Anxiety and Neurosis Review Group's Controlled Trials Register (CCDANCTR) to November 2013. We searched MEDLINE, Embase, PsycINFO and the Cochrane Central Register of Controlled Trials (CENTRAL) from 2013 to November 2023. No date or language restrictions were applied. ELIGIBILITY CRITERIA: We included randomised controlled trials (RCTs) in which exercise was compared to no treatment, inactive treatment or active treatment in adults (aged 18 years and over) with depression. We included trials that randomised individual participants or clusters. We excluded trials of postnatal depression. Two authors independently undertook study selection. OUTCOMES: The primary outcome we assessed was a measure of depression or mood at the end of treatment and at any longer-term follow-up. Other outcomes were treatment acceptability, quality of life, cost and adverse events. RISK OF BIAS: We assessed the risk of bias using the Cochrane risk of bias tool RoB 1. Two authors independently performed the risk of bias assessment. SYNTHESIS METHODS: Two authors independently extracted data on outcomes at the end of the trial and end of follow-up (if available). We calculated effect sizes for each trial using Hedges' g method and a mean difference (MD) or standardised mean difference (SMD) for the overall pooled effect for continuous data, and risk ratios for dichotomous data. Where trials used a number of different tools to assess depression, we included only the main outcome measure in our meta-analyses. Where trials provided several 'doses' of exercise, we used data from the largest dose and performed sensitivity analysis using the lower dose. We performed subgroup analysis to explore the influence of diagnostic method, exercise intensity, number of exercise sessions, type of exercise and type of control (i.e. placebo, no treatment, waiting list, usual care and self monitoring). Through our sensitivity analyses, we explored the influence of study risk of bias. INCLUDED STUDIES: We included 73 RCTs (at least 4985 participants) in the review, 69 of which contributed data to our meta-analyses. SYNTHESIS OF RESULTS: For the 57 trials (2189 participants) comparing exercise with no treatment or a control intervention, the pooled SMD for depressive symptoms at the end of treatment was -0.67 (95% confidence interval (CI) -0.82 to -0.52; low-certainty evidence), showing that exercise may result in a reduction in depressive symptoms. When we included only the seven trials (447 participants) with adequate allocation concealment, intention-to-treat analysis and blinded outcome assessment, the pooled SMD was smaller (SMD -0.46, 95% CI -0.88 to -0.04). Pooled data from the nine trials (405 participants) with long-term follow-up provided very uncertain evidence about the effect of exercise on depressive symptoms (SMD -0.53, 95% CI -1.11 to 0.06; very low certainty evidence). Ten trials (414 participants) compared exercise with psychological therapy, finding there is probably little to no difference in their effect on depressive symptoms at the end of treatment (SMD 0.03, 95% CI -0.16 to 0.23; moderate-certainty evidence). There were similar results at long-term follow-up (SMD -0.11, 95% CI -0.48 to 0.26; 4 studies, 114 participants; low-certainty evidence). Five trials (330 participants) compared exercise with pharmacological treatment, finding there may be little to no difference in their effect on depressive symptoms at the end of treatment (SMD -0.11, 95% CI -0.33 to 0.10; low-certainty evidence). The evidence was very uncertain at long-term follow-up (SMD -0.40, 95% CI -0.80 to 0.00; 1 study, 58 participants; very low certainty evidence). There did not appear to be a difference between exercise and other interventions in terms of treatment acceptability, as measured by participants completing the study (moderate to low certainty evidence). Results for the outcome 'quality of life' were inconsistent (low to very low certainty evidence). Adverse events were not common in any comparison, but included musculoskeletal injuries and depression affecting those undertaking exercise, and diarrhoea, sexual dysfunction and fatigue reported by those receiving sertraline. Many trials were affected by multiple sources of bias: randomisation was adequately concealed in only 22 studies, only 31 used intention-to-treat analyses, and only 23 used blinded outcome assessors. Blinding of those receiving and those delivering the interventions is inherently difficult; we judged all studies to be at high risk of performance bias. Many trials used participant self-report rating scales, which have the potential to bias findings. AUTHORS' CONCLUSIONS: Exercise may be moderately more effective than a control intervention for reducing symptoms of depression. Exercise appears to be no more or less effective than psychological or pharmacological treatments, though this conclusion is based on a few small trials. Long-term follow-up was rare. The addition of 35 RCTs (at least 2526 participants) to this update has had very little effect on the estimate of the benefit of exercise on symptoms of depression. If further research is to take place, it should focus on improving trial quality, assessing which characteristics of exercise are effective for different people, and exploring health equity. FUNDING: This review update had no grant funding. Review authors AC, JH, CH and CW were part-funded by the National Institute for Health and Care Research Applied Research Collaboration North West Coast (NIHR ARC NWC). The views expressed are those of the authors and not necessarily those of the NHS, NIHR or Department of Health and Social Care. REGISTRATION: Protocols and previous versions: DOI 10.1002/14651858.CD004366; DOI 10.1002/14651858.CD4366.pub2; DOI 10.1002/14651858.CD4366.pub3; DOI 10.1002/14651858.CD4366.pub4; DOI 10.1002/14651858.CD4366.pub5; DOI 10.1002/14651858.CD4366.pub6.",
         "The Cochrane database of systematic reviews",
         "2026",
         "Clegg AJ; Hill JE; Mullin DS; Harris C; Smith CJ; Lightbody CE; Dwan K; Cooney GM; Mead GE; Watkins CL"
        ]
       ],
       "shape": {
        "columns": 6,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>journal</th>\n",
       "      <th>year</th>\n",
       "      <th>authors</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>41527994</td>\n",
       "      <td>Surgical interventions for treating vesicovagi...</td>\n",
       "      <td>This is a protocol for a Cochrane Review (inte...</td>\n",
       "      <td>The Cochrane database of systematic reviews</td>\n",
       "      <td>2026</td>\n",
       "      <td>Okada Y; Matsushita T; Hasegawa T; Noma H; Ota...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>41524153</td>\n",
       "      <td>Physiology- versus angiography-guided percutan...</td>\n",
       "      <td>This is a protocol for a Cochrane Review (inte...</td>\n",
       "      <td>The Cochrane database of systematic reviews</td>\n",
       "      <td>2026</td>\n",
       "      <td>Higuchi S; Yamaji N; Noma H; Ito M; Yokota Y; ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>41510790</td>\n",
       "      <td>Cladribine for people with multiple sclerosis.</td>\n",
       "      <td>RATIONALE: Multiple sclerosis (MS) is a chroni...</td>\n",
       "      <td>The Cochrane database of systematic reviews</td>\n",
       "      <td>2026</td>\n",
       "      <td>Celani MG; Orso M; Melis M; Ercolani MV; Canti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>41510785</td>\n",
       "      <td>Oral iron supplements for children in malaria-...</td>\n",
       "      <td>RATIONALE: Iron deficiency anaemia is a common...</td>\n",
       "      <td>The Cochrane database of systematic reviews</td>\n",
       "      <td>2026</td>\n",
       "      <td>Itzkovich M; Neuberger A; Harris I; Yahav D; P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>41500513</td>\n",
       "      <td>Exercise for depression.</td>\n",
       "      <td>RATIONALE: Depression is a common cause of mor...</td>\n",
       "      <td>The Cochrane database of systematic reviews</td>\n",
       "      <td>2026</td>\n",
       "      <td>Clegg AJ; Hill JE; Mullin DS; Harris C; Smith ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       pmid                                              title  \\\n",
       "0  41527994  Surgical interventions for treating vesicovagi...   \n",
       "1  41524153  Physiology- versus angiography-guided percutan...   \n",
       "2  41510790     Cladribine for people with multiple sclerosis.   \n",
       "3  41510785  Oral iron supplements for children in malaria-...   \n",
       "4  41500513                           Exercise for depression.   \n",
       "\n",
       "                                            abstract  \\\n",
       "0  This is a protocol for a Cochrane Review (inte...   \n",
       "1  This is a protocol for a Cochrane Review (inte...   \n",
       "2  RATIONALE: Multiple sclerosis (MS) is a chroni...   \n",
       "3  RATIONALE: Iron deficiency anaemia is a common...   \n",
       "4  RATIONALE: Depression is a common cause of mor...   \n",
       "\n",
       "                                       journal  year  \\\n",
       "0  The Cochrane database of systematic reviews  2026   \n",
       "1  The Cochrane database of systematic reviews  2026   \n",
       "2  The Cochrane database of systematic reviews  2026   \n",
       "3  The Cochrane database of systematic reviews  2026   \n",
       "4  The Cochrane database of systematic reviews  2026   \n",
       "\n",
       "                                             authors  \n",
       "0  Okada Y; Matsushita T; Hasegawa T; Noma H; Ota...  \n",
       "1  Higuchi S; Yamaji N; Noma H; Ito M; Yokota Y; ...  \n",
       "2  Celani MG; Orso M; Melis M; Ercolani MV; Canti...  \n",
       "3  Itzkovich M; Neuberger A; Harris I; Yahav D; P...  \n",
       "4  Clegg AJ; Hill JE; Mullin DS; Harris C; Smith ...  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load abstracts\n",
    "abstracts = pd.read_csv(ABSTRACTS_CSV, dtype={\"pmid\": str, \"year\": str})\n",
    "print(f\"Total Cochrane reviews: {len(abstracts):,}\")\n",
    "abstracts.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "3f18b471",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Column types:\n",
      "pmid        object\n",
      "title       object\n",
      "abstract    object\n",
      "journal     object\n",
      "year        object\n",
      "authors     object\n",
      "dtype: object\n",
      "\n",
      "Missing values:\n",
      "pmid         0\n",
      "title        0\n",
      "abstract     0\n",
      "journal      0\n",
      "year         0\n",
      "authors     33\n",
      "dtype: int64\n",
      "\n",
      "Empty strings (non-null but blank):\n",
      "pmid        0\n",
      "title       0\n",
      "abstract    0\n",
      "journal     0\n",
      "year        0\n",
      "authors     0\n",
      "dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Basic info and missing values\n",
    "print(\"Column types:\")\n",
    "print(abstracts.dtypes)\n",
    "print(\"\\nMissing values:\")\n",
    "print(abstracts.isnull().sum())\n",
    "print(\"\\nEmpty strings (non-null but blank):\")\n",
    "print((abstracts == \"\").sum())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "05a00b1d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Year distribution\n",
    "abstracts[\"year_clean\"] = pd.to_numeric(abstracts[\"year\"].str[:4], errors=\"coerce\")\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(12, 4))\n",
    "abstracts[\"year_clean\"].dropna().astype(int).value_counts().sort_index().plot(kind=\"bar\", ax=ax)\n",
    "ax.set_xlabel(\"Year\")\n",
    "ax.set_ylabel(\"Number of Reviews\")\n",
    "ax.set_title(\"Cochrane Reviews by Publication Year\")\n",
    "plt.xticks(rotation=45)\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "fdbd62ac",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Abstract word count statistics:\n",
      "count    17092.000000\n",
      "mean       545.138603\n",
      "std        234.481107\n",
      "min         18.000000\n",
      "25%        387.000000\n",
      "50%        478.000000\n",
      "75%        706.000000\n",
      "max       4774.000000\n",
      "Name: abstract_words, dtype: float64\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Abstract length distribution\n",
    "abstracts[\"abstract_len\"] = abstracts[\"abstract\"].fillna(\"\").str.len()\n",
    "abstracts[\"abstract_words\"] = abstracts[\"abstract\"].fillna(\"\").str.split().str.len()\n",
    "\n",
    "print(\"Abstract word count statistics:\")\n",
    "print(abstracts[\"abstract_words\"].describe())\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(10, 4))\n",
    "abstracts[\"abstract_words\"].hist(bins=50, ax=ax, edgecolor=\"black\")\n",
    "ax.set_xlabel(\"Word Count\")\n",
    "ax.set_ylabel(\"Frequency\")\n",
    "ax.set_title(\"Distribution of Abstract Lengths (words)\")\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "63c0abac",
   "metadata": {},
   "source": [
    "## 2. Load and Inspect References"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "b90dd7df",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total reference edges: 1,182,678\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "citing_pmid",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "ref_pmid",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ref_doi",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ref_title",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "3b54ac7a-5b4f-4f4a-86f5-2436fed7dc28",
       "rows": [
        [
         "0",
         "41527994",
         null,
         null,
         "Hillary CJ, Osman NI, Hilton P, Chapple CR. The aetiology, treatment, and outcome of urogenital fistulae managed in well- and low-resourced countries: a systematic review. European Urology 2016;70(3):478-92. [DOI: 10.1016/j.eururo.2016.02.015]"
        ],
        [
         "1",
         "41527994",
         null,
         null,
         "Hilton P, Ward A. Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years' experience in southeast Nigeria. International Urogynecology Journal and Pelvic Floor Dysfunction 1998;9(4):189-94. [DOI: 10.1007/BF01901602]"
        ],
        [
         "2",
         "41527994",
         null,
         null,
         "Ahmed S, Genadry R, Asiamah B, Liang M, Tripathi V, Anastasi E. Global, regional and national estimates of obstetric fistula prevalence. BMJ Global Health 2025;10(12):e020877. [DOI: 10.1136/bmjgh-2025-020877]"
        ],
        [
         "3",
         "41527994",
         null,
         null,
         "World Health Organization (WHO). International day to end obstetric fistula: call for quality maternal health care for all. www.emro.who.int/media/news/international-day-to-end-obstetric-fistula-call-for-quality-maternal-health-care-for-all.html (accessed 26 December 2025)."
        ],
        [
         "4",
         "41527994",
         null,
         null,
         "Adler AJ, Ronsmans C, Calvert C, Filippi V. Estimating the prevalence of obstetric fistula: a systematic review and meta-analysis. BMC Pregnancy and Childbirth 2013;13:246. [DOI: 10.1186/1471-2393-13-246]"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>citing_pmid</th>\n",
       "      <th>ref_pmid</th>\n",
       "      <th>ref_doi</th>\n",
       "      <th>ref_title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>41527994</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hillary CJ, Osman NI, Hilton P, Chapple CR. Th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>41527994</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hilton P, Ward A. Epidemiological and surgical...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>41527994</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ahmed S, Genadry R, Asiamah B, Liang M, Tripat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>41527994</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>World Health Organization (WHO). International...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>41527994</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adler AJ, Ronsmans C, Calvert C, Filippi V. Es...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  citing_pmid ref_pmid ref_doi  \\\n",
       "0    41527994      NaN     NaN   \n",
       "1    41527994      NaN     NaN   \n",
       "2    41527994      NaN     NaN   \n",
       "3    41527994      NaN     NaN   \n",
       "4    41527994      NaN     NaN   \n",
       "\n",
       "                                           ref_title  \n",
       "0  Hillary CJ, Osman NI, Hilton P, Chapple CR. Th...  \n",
       "1  Hilton P, Ward A. Epidemiological and surgical...  \n",
       "2  Ahmed S, Genadry R, Asiamah B, Liang M, Tripat...  \n",
       "3  World Health Organization (WHO). International...  \n",
       "4  Adler AJ, Ronsmans C, Calvert C, Filippi V. Es...  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load references\n",
    "refs = pd.read_csv(REFERENCES_CSV, dtype={\"citing_pmid\": str, \"ref_pmid\": str})\n",
    "print(f\"Total reference edges: {len(refs):,}\")\n",
    "refs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "15ed567e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cochrane reviews with at least one reference: 10,105\n",
      "Reviews without references: 6,987\n"
     ]
    }
   ],
   "source": [
    "# How many unique Cochrane reviews have references?\n",
    "reviews_with_refs = refs[\"citing_pmid\"].nunique()\n",
    "print(f\"Cochrane reviews with at least one reference: {reviews_with_refs:,}\")\n",
    "print(f\"Reviews without references: {len(abstracts) - reviews_with_refs:,}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "45ff55bd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "References per Cochrane review:\n",
      "count    10105.000000\n",
      "mean       117.038892\n",
      "std        112.297287\n",
      "min          2.000000\n",
      "25%         54.000000\n",
      "50%         84.000000\n",
      "75%        139.000000\n",
      "max       1890.000000\n",
      "dtype: float64\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# References per review\n",
    "refs_per_review = refs.groupby(\"citing_pmid\").size()\n",
    "\n",
    "print(\"References per Cochrane review:\")\n",
    "print(refs_per_review.describe())\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(10, 4))\n",
    "refs_per_review.hist(bins=50, ax=ax, edgecolor=\"black\")\n",
    "ax.set_xlabel(\"Number of References\")\n",
    "ax.set_ylabel(\"Number of Reviews\")\n",
    "ax.set_title(\"Distribution of Reference Counts per Cochrane Review\")\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "cc36dc34",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "References with PMID: 848,607 (71.8%)\n",
      "References with DOI:  141,573 (12.0%)\n",
      "References with either: 865,992 (73.2%)\n",
      "References with neither (title only): 316,686\n"
     ]
    }
   ],
   "source": [
    "# How many references have resolvable PMIDs?\n",
    "has_pmid = refs[\"ref_pmid\"].notna() & (refs[\"ref_pmid\"] != \"\")\n",
    "has_doi = refs[\"ref_doi\"].notna() & (refs[\"ref_doi\"] != \"\")\n",
    "\n",
    "print(f\"References with PMID: {has_pmid.sum():,} ({100*has_pmid.mean():.1f}%)\")\n",
    "print(f\"References with DOI:  {has_doi.sum():,} ({100*has_doi.mean():.1f}%)\")\n",
    "print(f\"References with either: {(has_pmid | has_doi).sum():,} ({100*(has_pmid | has_doi).mean():.1f}%)\")\n",
    "print(f\"References with neither (title only): {(~has_pmid & ~has_doi).sum():,}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "e6cc3424",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unique referenced papers with PMIDs: 491,531\n",
      "These are the papers we can potentially fetch abstracts for and use in our screening task.\n"
     ]
    }
   ],
   "source": [
    "# Unique referenced papers with PMIDs\n",
    "unique_ref_pmids = refs.loc[has_pmid, \"ref_pmid\"].nunique()\n",
    "print(f\"Unique referenced papers with PMIDs: {unique_ref_pmids:,}\")\n",
    "print(\"These are the papers we can potentially fetch abstracts for and use in our screening task.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d98c1264",
   "metadata": {},
   "source": [
    "## 3. Key Insight: Building Ground Truth\n",
    "\n",
    "The references in a Cochrane review represent **included** studies  papers that passed the screening criteria.\n",
    "\n",
    "To build a ground-truth dataset for LLM evaluation, we need:\n",
    "1. **Positive examples (included):** Papers that appear in the reference list of a review\n",
    "2. **Negative examples (excluded):** Papers that could have been considered but were NOT included\n",
    "\n",
    "The challenge: We don't have explicit \"excluded\" papers from Cochrane. Possible strategies:\n",
    "- Use papers from the same topic/search that weren't included\n",
    "- Sample random health papers as negatives\n",
    "- Use papers referenced by related reviews but not by a specific one"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d3c7a4e1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Top 10 Cochrane reviews by reference count:\n",
      "  PMID 29543326: 1890 refs  Non-invasive diagnostic tests for Helicobacter pylori infection.\n",
      "  PMID 33075160: 1788 refs  Drugs for preventing postoperative nausea and vomiting in adults after general a...\n",
      "  PMID 21678355: 1231 refs  Antipsychotic medication for early episode schizophrenia.\n",
      "  PMID 37436070: 1156 refs  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta...\n",
      "  PMID 22419320: 1151 refs  Antioxidant supplements for prevention of mortality in healthy participants and ...\n",
      "  PMID 36971690: 1087 refs  Methylphenidate for children and adolescents with attention deficit hyperactivit...\n",
      "  PMID 41342306: 1087 refs  Methylphenidate for children and adolescents with attention deficit hyperactivit...\n",
      "  PMID 35603936: 1085 refs  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta...\n",
      "  PMID 39625083: 1056 refs  Exercise for osteoarthritis of the knee.\n",
      "  PMID 38032037: 1033 refs  Methods to increase response to postal and electronic questionnaires.\n"
     ]
    }
   ],
   "source": [
    "# Sample: Pick a few reviews to examine their reference patterns\n",
    "top_reviews = refs_per_review.nlargest(10)\n",
    "print(\"Top 10 Cochrane reviews by reference count:\")\n",
    "for pmid, count in top_reviews.items():\n",
    "    title = abstracts.loc[abstracts[\"pmid\"] == pmid, \"title\"].values\n",
    "    title_str = title[0][:80] + \"...\" if len(title) > 0 and len(title[0]) > 80 else (title[0] if len(title) > 0 else \"N/A\")\n",
    "    print(f\"  PMID {pmid}: {count} refs  {title_str}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d2d0e40f",
   "metadata": {},
   "source": [
    "## 4. Summary & Next Steps\n",
    "\n",
    "### Data Summary\n",
    "- **Cochrane reviews:** ~17K with abstracts\n",
    "- **Reference edges:** ~1.2M\n",
    "- **Unique referenced papers with PMIDs:** (see above)\n",
    "\n",
    "### Next Steps\n",
    "1. **Fetch abstracts for referenced papers**  We need the text of included papers\n",
    "2. **Design negative sampling strategy**  How to get \"excluded\" examples\n",
    "3. **Extract inclusion/exclusion criteria** from Cochrane abstract text (often in METHODS section)\n",
    "4. **Build annotated validation set**  Sample ~500-1000 (paper, review, label) tuples"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
